1984
DOI: 10.1159/000280943
|View full text |Cite
|
Sign up to set email alerts
|

Renal Carcinoma with Solitary Distant Metastasis

Abstract: Our experience with 14 patients with renal cell carcinoma and solitary distant metastasis is reported. The treatment of choice is tumor nephrectomy and surgical removal of the metastasis simultaneously or within a short period of time. The average survival time with this treatment is 18.5 months (maximum 4 years, minimum 2 months).

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

2
3
0

Year Published

1986
1986
2003
2003

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 7 publications
(5 citation statements)
references
References 5 publications
2
3
0
Order By: Relevance
“…The survival of the patients reported by us is considerably better than the results of nephrectomy and removal of solitary metastasis in pa tients with hypernephroma. No such patient survived 4 years [9,10]. Actually, our patient survival at 5 years is the same as reported by many authors for radical nephrec tomy of only one kidney [7],…”
Section: Discussionsupporting
confidence: 84%
“…The survival of the patients reported by us is considerably better than the results of nephrectomy and removal of solitary metastasis in pa tients with hypernephroma. No such patient survived 4 years [9,10]. Actually, our patient survival at 5 years is the same as reported by many authors for radical nephrec tomy of only one kidney [7],…”
Section: Discussionsupporting
confidence: 84%
“…This difference is more pronounced if the interval between nephrectomy and the appearance of metastases exceeds 2 years [8]. With late metastases, the 5-years survival rate of 45% is similar to that of patients with non-metastatic carcinoma [9]. In the present case, the metastatic disease was noted 2 months after nephrectomy, and the patient was apparently well 2 months later.…”
Section: Discussionsupporting
confidence: 64%
“…Renal adenocarcinoma is usually metastasizes in the early phase of follow‐up. The lung, bone, lymph node and liver are major sites of metastatic spread 10 . Malignant involvement of the ipsilateral adrenal gland is noted only in 1.2–10% 2–5 .…”
Section: Discussionmentioning
confidence: 99%
“…The lung, bone, lymph node and liver are major sites of metastatic spread. 10 Malignant involvement of the ipsilateral adrenal gland is noted only in 1.2-10%. [2][3][4][5] Moreover, contralateral adrenal involvement by RCC is extremely rare.…”
Section: Discussionmentioning
confidence: 99%